115 related articles for article (PubMed ID: 38906226)
1. PLK-3-mediated phosphorylation of BAP1 prevents diabetic retinopathy.
Qin T; Lv Y; Xi X; Wu Z
Biochem Pharmacol; 2024 Jun; 226():116374. PubMed ID: 38906226
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑126 suppresses the proliferation and migration of endothelial cells in experimental diabetic retinopathy by targeting polo‑like kinase 4.
Zheng Y; Liu Y; Wang L; Xu H; Lu Z; Xuan Y; Meng W; Ye L; Fang D; Zhou Y; Ke K; Liu Y; An M
Int J Mol Med; 2021 Jan; 47(1):151-160. PubMed ID: 33416109
[TBL] [Abstract][Full Text] [Related]
3. NADH-Cytochrome B5 reductase 2 suppresses retinal vascular dysfunction through regulation of vascular endothelial growth factor A in diabetic retinopathy.
Chen J; Sun Y; Chen L; Zhou Y
Exp Eye Res; 2022 Sep; 222():109186. PubMed ID: 35820466
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of glycoprotein non-metastatic melanoma protein B prevents high glucose-induced angiogenesis in diabetic retinopathy.
Qin T; Xi X; Wu Z
Mol Cell Biochem; 2023 Apr; 478(4):697-706. PubMed ID: 36036335
[TBL] [Abstract][Full Text] [Related]
5. miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.
Liu X; Li J; Li X
Int J Immunopathol Pharmacol; 2020; 34():2058738420909041. PubMed ID: 32116075
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of co-culture and monoculture models in simulating diabetic neurovascular dysfunction: insights into diabetic retinopathy.
Wang Q; Qiao Z; Kang W; Zhu L; Zhang X
Front Endocrinol (Lausanne); 2023; 14():1215218. PubMed ID: 37745714
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Drp1 ameliorates diabetic retinopathy by regulating mitochondrial homeostasis.
Zhang MY; Zhu L; Bao X; Xie TH; Cai J; Zou J; Wang W; Gu S; Li Y; Li HY; Yao Y; Wei TT
Exp Eye Res; 2022 Jul; 220():109095. PubMed ID: 35490835
[TBL] [Abstract][Full Text] [Related]
8.
Zhang J; Zhang X; Zou Y; Han F
Arch Physiol Biochem; 2022 Jun; 128(3):708-715. PubMed ID: 32046510
[TBL] [Abstract][Full Text] [Related]
9. Genipin ameliorates diabetic retinopathy via the HIF-1α and AGEs-RAGE pathways.
Sun K; Chen Y; Zheng S; Wan W; Hu K
Phytomedicine; 2024 Jul; 129():155596. PubMed ID: 38626646
[TBL] [Abstract][Full Text] [Related]
10. Lnc-216 regulates the miR-143-5p /MMP2 signaling axis aggravates retinal endothelial cell dysfunction.
Wang F; Guo Z; Yang G; Yang F; Zhou Q; Lv H
Clin Hemorheol Microcirc; 2024 Jun; ():. PubMed ID: 38943385
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia-induced effects on glycocalyx components in the retina.
Kaur G; Rogers J; Rashdan NA; Cruz-Topete D; Pattillo CB; Hartson SD; Harris NR
Exp Eye Res; 2021 Dec; 213():108846. PubMed ID: 34801534
[TBL] [Abstract][Full Text] [Related]
12. [Wogonoside alleviates high glucose-induced dysfunction of retinal microvascular endothelial cells and diabetic retinopathy in rats by up-regulating SIRT1].
Shao X; Yu J; Ni W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):463-472. PubMed ID: 35527482
[TBL] [Abstract][Full Text] [Related]
13. eIF4A3-mediated circEHMT1 regulation in retinal microvascular endothelial dysfunction in diabetic retinopathy.
Wang Y; Zhang Y; Qu Y; Li S; Xi W; Liu B; Ye L
Microvasc Res; 2024 Jan; 151():104612. PubMed ID: 37839527
[TBL] [Abstract][Full Text] [Related]
14. DNMT1-mediated lncRNA MEG3 methylation accelerates endothelial-mesenchymal transition in diabetic retinopathy through the PI3K/Akt/mTOR signaling pathway.
He Y; Dan Y; Gao X; Huang L; Lv H; Chen J
Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E598-E608. PubMed ID: 33284093
[TBL] [Abstract][Full Text] [Related]
15. RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy.
Dong L; Zhang Z; Liu X; Wang Q; Hong Y; Li X; Liu J
J Mol Med (Berl); 2021 Feb; 99(2):225-240. PubMed ID: 33188599
[TBL] [Abstract][Full Text] [Related]
16. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling.
Zhu L; Wang W; Xie TH; Zou J; Nie X; Wang X; Zhang MY; Wang ZY; Gu S; Zhuang M; Tan J; Shen C; Dai Y; Yang X; Yao Y; Wei TT
FASEB J; 2020 Mar; 34(3):4189-4203. PubMed ID: 31957105
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA TUG1 alleviates diabetic retinal vascular dysfunction through regulating miR-524-5p/FGFR2.
Tian M; Yang J; Yan X; Cao Y; Liu Y; Lei Y; Lv H
Bioengineered; 2022 May; 13(5):12661-12672. PubMed ID: 35599572
[TBL] [Abstract][Full Text] [Related]
18. VEGF promotes diabetic retinopathy by upregulating the PKC/ET/NF-κB/ICAM-1 signaling pathway.
Zhang M; Zhou M; Cai X; Zhou Y; Jiang X; Luo Y; Hu Y; Qiu R; Wu Y; Zhang Y; Xiong Y
Eur J Histochem; 2022 Oct; 66(4):. PubMed ID: 36305269
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells-derived small extracellular vesicles alleviate diabetic retinopathy by delivering NEDD4.
Sun F; Sun Y; Zhu J; Wang X; Ji C; Zhang J; Chen S; Yu Y; Xu W; Qian H
Stem Cell Res Ther; 2022 Jul; 13(1):293. PubMed ID: 35841055
[TBL] [Abstract][Full Text] [Related]
20. Protection of tauroursodeoxycholic acid on high glucose-induced human retinal microvascular endothelial cells dysfunction and streptozotocin-induced diabetic retinopathy rats.
Wang CF; Yuan JR; Qin D; Gu JF; Zhao BJ; Zhang L; Zhao D; Chen J; Hou XF; Yang N; Bu WQ; Wang J; Li C; Tian G; Dong ZB; Feng L; Jia XB
J Ethnopharmacol; 2016 Jun; 185():162-70. PubMed ID: 26988565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]